Songqing L. He

No.6 Shuangyong Road
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

TRIM31 promotes lenvatinib resistance and stemness in hepatocellular carcinoma through K48/K63-linked ubiquitination of GLDC.

TRIM31 promotes lenvatinib resistance and stemness in hepatocellular carcinoma through K48/K63-linked ubiquitination of GLDC.

Journal: Acta biochimica et biophysica Sinica

Published: July 30, 2026

Retraction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.

Retraction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.

Journal: Oncotarget

Published: April 23, 2026

Establishment and validation of a prognostic model for pancreatic cancer utilizing genes of tumor-associated neutrophils.

Establishment and validation of a prognostic model for pancreatic cancer utilizing genes of tumor-associated neutrophils.

Journal: Discover oncology

Published: March 20, 2026

Impact of age on safety of pancreaticoduodenectomy: a nationwide cohort study stratified by surgical approach and anastomotic technique with optimal age cut-off analysis.

Impact of age on safety of pancreaticoduodenectomy: a nationwide cohort study stratified by surgical approach and anastomotic technique with optimal age cut-off analysis.

Journal: Science China. Life sciences

Published: February 10, 2026

Identification of mitochondrial dysfunction-related biomarkers and immune infiltration in liver ischemia-reperfusion injury via integrated bioinformatics and machine learning.

Identification of mitochondrial dysfunction-related biomarkers and immune infiltration in liver ischemia-reperfusion injury via integrated bioinformatics and machine learning.

Journal: Biochemical and biophysical research communications

Published: January 10, 2026

CapeOx -HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A multicenter propensity score-matched analysis.

CapeOx -HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A multicenter propensity score-matched analysis.

Journal: Surgical oncology

Published: January 07, 2026

Establishment and validation of a diagnostic model for evaluating synchronous liver metastasis in pancreatic cancer using comprehensive blood biochemical indicators.

Establishment and validation of a diagnostic model for evaluating synchronous liver metastasis in pancreatic cancer using comprehensive blood biochemical indicators.

Journal: Oncology letters

Published: December 15, 2025

Evaluation of therapeutic efficacy in hepatocellular carcinoma ablation based on CT radiomics and deep learning multimodal models.

Evaluation of therapeutic efficacy in hepatocellular carcinoma ablation based on CT radiomics and deep learning multimodal models.

Journal: Frontiers in oncology

Published: December 09, 2025

Regulation of natural killer cell subtypes and functions by programmed cell death protein 1 and its receptor at the maternal-fetal interface in mice infected with Toxoplasma gondii during the second trimester

Regulation of natural killer cell subtypes and functions by programmed cell death protein 1 and its receptor at the maternal-fetal interface in mice infected with Toxoplasma gondii during the second trimester

Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control

Published: December 02, 2025

JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1.

JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1.

Journal: Gut

Published: October 20, 2025

Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma.

Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma.

Journal: Gut

Published: October 20, 2025

Development and external validation of a novel online calculator for predicting long-term survival following radical hepatectomy in patients with BCLC stage 0/A hepatocellular carcinoma and clinically significant portal hypertension.

Development and external validation of a novel online calculator for predicting long-term survival following radical hepatectomy in patients with BCLC stage 0/A hepatocellular carcinoma and clinically significant portal hypertension.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 07, 2025

Showing 1-12 of 137

Last Updated: 09/26/2026